Insulet
PODD
C$396.02
Share price
-2.72%
Change (1 day)
42.76%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$2.99 Billion
According to Insulet's latest financial reports the company's total liabilities are C$2.99 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Insulet - Total liabilities on balance sheet (from 2005 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$2.69 B | 9.39% |
| 2023-12-31 | C$2.46 B | 2.2% |
| 2022-12-31 | C$2.40 B | 26.61% |
| 2021-12-31 | C$1.90 B | 17.53% |
| 2020-12-31 | C$1.61 B | 16.14% |
| 2019-12-31 | C$1.39 B | 42.76% |
| 2018-12-31 | C$0.97 B | 17.96% |
| 2017-12-31 | C$0.82 B | 56.5% |
| 2016-12-31 | C$0.52 B | 58.13% |
| 2015-12-31 | C$0.33 B | 35.07% |
| 2014-12-31 | C$0.24 B | 42.38% |
| 2013-12-31 | C$0.17 B | 13.64% |
| 2012-12-31 | C$0.15 B | 8.55% |
| 2011-12-31 | C$0.14 B | 56.69% |
| 2010-12-31 | C$89.96 M | -28.02% |
| 2009-12-31 | C$0.12 B | 28.29% |
| 2008-12-31 | C$97.42 M | 153.89% |
| 2007-12-31 | C$38.37 M | -79.26% |
| 2006-12-31 | C$0.18 B | 91.73% |
| 2005-12-31 | C$96.49 M | 12.16% |
| 2004-12-31 | C$86.03 M | 86.26% |
| 2003-12-31 | C$46.19 M | -19.13% |
| 2002-12-31 | C$57.11 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ICU Medical
ICUI | C$3.00 B | 0.47% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | C$1.04 B | -64.93% | 🇺🇸 USA |
 DexCom DXCM | C$6.13 B | 105.12% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$158.18 B | 5,185.01% | 🇺🇸 USA |
 Abbott Laboratories ABT | C$44.32 B | 1,381.02% | 🇺🇸 USA |
 Medtronic MDT | C$59.43 B | 1,885.91% | 🇮🇪 Ireland |
 Eli Lilly LLY | C$100.66 B | 3,263.30% | 🇺🇸 USA |